Novo: Expect to Take Wegovy Longer Than Older Drugs

Published on January 9, 2024

Novo Nordisk’s CEO said on Tuesday he expects patients will stick with the company’s popular obesity drug Wegovy for far longer than those using older treatments. “We know from all medical interventions, stay time is not like a 100%… but I think we will see a significantly…

Read Full Article (External Site)